Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 37950801)

  • 21. Adoptive cellular immunotherapy for solid neoplasms beyond CAR-T.
    Liu Q; Li J; Zheng H; Yang S; Hua Y; Huang N; Kleeff J; Liao Q; Wu W
    Mol Cancer; 2023 Feb; 22(1):28. PubMed ID: 36750830
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colorectal Cancer Immune Infiltrates: Significance in Patient Prognosis and Immunotherapeutic Efficacy.
    Guo L; Wang C; Qiu X; Pu X; Chang P
    Front Immunol; 2020; 11():1052. PubMed ID: 32547556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An Ex Vivo 3D Tumor Microenvironment-Mimicry Culture to Study TAM Modulation of Cancer Immunotherapy.
    Li YR; Yu Y; Kramer A; Hon R; Wilson M; Brown J; Yang L
    Cells; 2022 May; 11(9):. PubMed ID: 35563889
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response?
    O'Malley G; Heijltjes M; Houston AM; Rani S; Ritter T; Egan LJ; Ryan AE
    Oncotarget; 2016 Sep; 7(37):60752-60774. PubMed ID: 27542276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adoptive NK Cell Transfer as a Treatment in Colorectal Cancer Patients: Analyses of Tumour Cell Determinants Correlating With Efficacy
    Lanuza PM; Alonso MH; Hidalgo S; Uranga-Murillo I; García-Mulero S; Arnau R; Santos C; Sanjuan X; Santiago L; Comas L; Redrado S; Pazo-Cid R; Agustin-Ferrández MJ; Jaime-Sánchez P; Pesini C; Gálvez EM; Ramírez-Labrada A; Arias M; Sanz-Pamplona R; Pardo J
    Front Immunol; 2022; 13():890836. PubMed ID: 35747143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multifunctional nanodrug performs sonodynamic therapy and inhibits TGF-β to boost immune response against colorectal cancer and liver metastasis.
    Huang S; Ding D; Lan T; He G; Ren J; Liang R; Zhong H; Chen G; Lu X; Shuai X; Wei B
    Acta Biomater; 2023 Jul; 164():538-552. PubMed ID: 37037269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrative analysis revealed that distinct cuprotosis patterns reshaped tumor microenvironment and responses to immunotherapy of colorectal cancer.
    Xu X; Ding C; Zhong H; Qin W; Shu D; Yu M; Abuduaini N; Zhang S; Yang X; Feng B
    Front Immunol; 2023; 14():1165101. PubMed ID: 37006250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy.
    Gaggero S; Witt K; Carlsten M; Mitra S
    Front Immunol; 2020; 11():621225. PubMed ID: 33584718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor microenvironment-associated gene C3 can predict the prognosis of colorectal adenocarcinoma: a study based on TCGA.
    Liu Y; Wang X
    Clin Transl Oncol; 2021 Sep; 23(9):1923-1933. PubMed ID: 33765255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Emergence of Immune-checkpoint Inhibitors in Colorectal Cancer Therapy.
    Ghidini M; Fusco N; Salati M; Khakoo S; Tomasello G; Petrelli F; Trapani D; Petrillo A
    Curr Drug Targets; 2021; 22(9):1021-1033. PubMed ID: 33563194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Colorectal Cancer-Associated Immune Exhaustion Involves T and B Lymphocytes and Conventional NK Cells and Correlates With a Shorter Overall Survival.
    Sorrentino C; D'Antonio L; Fieni C; Ciummo SL; Di Carlo E
    Front Immunol; 2021; 12():778329. PubMed ID: 34975867
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.
    Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M
    J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Future of Cancer Diagnosis, Treatment and Surveillance: A Systemic Review on Immunotherapy and Immuno-PET Radiotracers.
    Liberini V; Laudicella R; Capozza M; Huellner MW; Burger IA; Baldari S; Terreno E; Deandreis D
    Molecules; 2021 Apr; 26(8):. PubMed ID: 33920423
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unleashing Natural Killer Cells in the Tumor Microenvironment-The Next Generation of Immunotherapy?
    Ben-Shmuel A; Biber G; Barda-Saad M
    Front Immunol; 2020; 11():275. PubMed ID: 32153582
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-cell transcriptome analysis reveals immunosuppressive landscape in overweight and obese colorectal cancer.
    Xiao G; Zheng Y; Chen H; Luo M; Yang C; Ren D; Qin P; Zhang H; Lin H
    J Transl Med; 2024 Feb; 22(1):134. PubMed ID: 38311726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and validation of immunotherapy for four novel clusters of colorectal cancer based on the tumor microenvironment.
    Zheng X; Ma Y; Bai Y; Huang T; Lv X; Deng J; Wang Z; Lian W; Tong Y; Zhang X; Yue M; Zhang Y; Li L; Peng M
    Front Immunol; 2022; 13():984480. PubMed ID: 36389763
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune-infiltrating signature-based classification reveals CD103
    Luo Y; Zong Y; Hua H; Gong M; Peng Q; Li C; Neculai D; Zeng X
    Front Immunol; 2022; 13():1011590. PubMed ID: 36311750
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current advancements and future perspectives of immunotherapy in colorectal cancer research.
    Kishore C; Bhadra P
    Eur J Pharmacol; 2021 Feb; 893():173819. PubMed ID: 33347822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances in CAR-T cells therapy for colorectal cancer.
    Qin X; Wu F; Chen C; Li Q
    Front Immunol; 2022; 13():904137. PubMed ID: 36238297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer.
    Chen H; Yao J; Bao R; Dong Y; Zhang T; Du Y; Wang G; Ni D; Xun Z; Niu X; Ye Y; Li HB
    Mol Cancer; 2021 Feb; 20(1):29. PubMed ID: 33557837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.